Finance

Beta
Lists
AVIR:NASDAQ
Atea Pharmaceuticals Inc
$4.25
-3.85%
(-0.17) 1D
$4.25
0.00% (0.00)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AVIR...
Open
$4.42
High
$4.43
Low
$4.24
Mkt. cap
340.12M
Avg. vol.
326.34K
Volume
217.60K
52-wk high
$6.45
52-wk low
$2.78
EPS
-$2.12
Beta
0.32
Shares outstanding
80.03M
No. of employees
55
Open
$4.42
High
$4.43
Low
$4.24
Mkt. cap
340.12M
Avg. vol.
326.34K
Volume
217.60K
52-wk high
$6.45
52-wk low
$2.78
EPS
-$2.12
Beta
0.32
Shares outstanding
80.03M
No. of employees
55
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to AVIR in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for AVIR in the last 3 months.
Highest
Current $4.25
$10.00 (+135.29%)
Average
$8.00 (+88.24%)
Lowest
$6.00 (+41.18%)
News stories
From sources across the web
About Atea Pharmaceuticals Inc
CEO-
Employees55
Founded2012
HeadquartersBoston, Massachusetts, United States
SectorPharmaceutical industry
Websiteateapharma.com
Last report
May 12, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.57 / -$0.56
-2.70%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
32.35M
38.23M
47.60M
41.13M
Cost of revenue
32.35M
38.23M
47.60M
41.13M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.07M
7.22M
7.12M
6.87M
Operating expense
9.07M
7.22M
7.12M
6.87M
Total operating expenses
41.42M
45.45M
54.71M
48.01M
Operating income
-41.42M
-45.45M
-54.71M
-48.01M
Other non operating income
-
-
-
-
EBT including unusual items
-36.95M
-41.85M
-51.64M
-45.39M
EBT excluding unusual items
-37.03M
-41.74M
-51.41M
-45.39M
Income tax expense
207.00K
196.00K
-6.77M
50.00K
Effective tax rate
-0.56%
-0.47%
13.11%
-0.11%
Other operating expenses
-
-
-
-
Net income
-37.16M
-42.05M
-44.87M
-45.44M
Net profit margin
-
-
-
-
Earnings per share
-0.44
-0.53
-0.57
-0.57
Interest and investment income
4.39M
3.71M
3.30M
2.62M
Interest expense
-
-
-
-
Net interest expenses
4.39M
3.71M
3.30M
2.62M
Depreciation and amortization charges
-
-
-
-
EBITDA
-41.32M
-45.35M
-54.61M
-47.90M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer